Cargando…

Birthweight, childhood body size, and timing of puberty and risks of breast cancer by menopausal status and tumor receptor subtypes

BACKGROUND: Associations of birthweight, childhood body size and pubertal timing with breast cancer risks by menopausal status and tumor receptor subtypes are inconclusive. Thus, we investigated these associations in a population-based cohort of Danish women. METHODS: We studied 162,419 women born b...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedersen, Dorthe C., Jensen, Britt W., Tjønneland, Anne, Andersen, Zorana J., Mellemkjaer, Lene, Bjerregaard, Lise G., Aarestrup, Julie, Baker, Jennifer L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652814/
https://www.ncbi.nlm.nih.gov/pubmed/36369105
http://dx.doi.org/10.1186/s13058-022-01578-0
_version_ 1784828556481658880
author Pedersen, Dorthe C.
Jensen, Britt W.
Tjønneland, Anne
Andersen, Zorana J.
Mellemkjaer, Lene
Bjerregaard, Lise G.
Aarestrup, Julie
Baker, Jennifer L.
author_facet Pedersen, Dorthe C.
Jensen, Britt W.
Tjønneland, Anne
Andersen, Zorana J.
Mellemkjaer, Lene
Bjerregaard, Lise G.
Aarestrup, Julie
Baker, Jennifer L.
author_sort Pedersen, Dorthe C.
collection PubMed
description BACKGROUND: Associations of birthweight, childhood body size and pubertal timing with breast cancer risks by menopausal status and tumor receptor subtypes are inconclusive. Thus, we investigated these associations in a population-based cohort of Danish women. METHODS: We studied 162,419 women born between 1930 and 1996 from the Copenhagen School Health Records Register. The register includes information on birthweight, measured childhood weights and heights at the age of 7–13 years, and computed ages at the onset of the growth spurt (OGS) and at peak height velocity (PHV). The Danish Breast Cancer Cooperative Group database provided information on breast cancer (n = 7510), including estrogen receptor (ER), human epidermal growth factor receptor 2 (HER2) and menopausal status. Hormone replacement therapy use came from the Danish National Prescription Registry. Hazard ratios (HR) and 95% confidence intervals (CI) were estimated by Cox regression. RESULTS: We found that birthweight was not associated with any breast cancer subtypes. While childhood BMI was not statistically significantly associated with ER+ tumors nor consistently with ER− tumors among pre-menopausal women, consistent inverse associations were found among postmenopausal women. At the age of 7 years, the HRs for postmenopausal ER+ and ER− tumors were 0.90 (95% CI 0.87–0.93) and 0.84 (95% CI 0.79–0.91) per BMI z-score, respectively. Similarly, childhood BMI was inversely associated with pre- and postmenopausal HER2− tumors, but not with HER2+ tumors. Childhood height was positively associated with both pre- and postmenopausal ER+ tumors, but not with ER− tumors. At the age of 7 years, the HRs for postmenopausal ER+ and ER− tumors were 1.09 (95% CI 1.06–1.12) and 1.02 (95% CI 0.96–1.09) per height z-score, respectively. In general, childhood height was positively associated with HER2+ and HER2− tumors among pre- and postmenopausal women. Ages at OGS and PHV were not associated with any breast cancer subtypes. CONCLUSIONS: We showed that a high BMI and short stature in childhood are associated with reduced risks of certain breast cancer subtypes. Thus, childhood body composition may play a role in the development of breast cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13058-022-01578-0.
format Online
Article
Text
id pubmed-9652814
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96528142022-11-15 Birthweight, childhood body size, and timing of puberty and risks of breast cancer by menopausal status and tumor receptor subtypes Pedersen, Dorthe C. Jensen, Britt W. Tjønneland, Anne Andersen, Zorana J. Mellemkjaer, Lene Bjerregaard, Lise G. Aarestrup, Julie Baker, Jennifer L. Breast Cancer Res Research BACKGROUND: Associations of birthweight, childhood body size and pubertal timing with breast cancer risks by menopausal status and tumor receptor subtypes are inconclusive. Thus, we investigated these associations in a population-based cohort of Danish women. METHODS: We studied 162,419 women born between 1930 and 1996 from the Copenhagen School Health Records Register. The register includes information on birthweight, measured childhood weights and heights at the age of 7–13 years, and computed ages at the onset of the growth spurt (OGS) and at peak height velocity (PHV). The Danish Breast Cancer Cooperative Group database provided information on breast cancer (n = 7510), including estrogen receptor (ER), human epidermal growth factor receptor 2 (HER2) and menopausal status. Hormone replacement therapy use came from the Danish National Prescription Registry. Hazard ratios (HR) and 95% confidence intervals (CI) were estimated by Cox regression. RESULTS: We found that birthweight was not associated with any breast cancer subtypes. While childhood BMI was not statistically significantly associated with ER+ tumors nor consistently with ER− tumors among pre-menopausal women, consistent inverse associations were found among postmenopausal women. At the age of 7 years, the HRs for postmenopausal ER+ and ER− tumors were 0.90 (95% CI 0.87–0.93) and 0.84 (95% CI 0.79–0.91) per BMI z-score, respectively. Similarly, childhood BMI was inversely associated with pre- and postmenopausal HER2− tumors, but not with HER2+ tumors. Childhood height was positively associated with both pre- and postmenopausal ER+ tumors, but not with ER− tumors. At the age of 7 years, the HRs for postmenopausal ER+ and ER− tumors were 1.09 (95% CI 1.06–1.12) and 1.02 (95% CI 0.96–1.09) per height z-score, respectively. In general, childhood height was positively associated with HER2+ and HER2− tumors among pre- and postmenopausal women. Ages at OGS and PHV were not associated with any breast cancer subtypes. CONCLUSIONS: We showed that a high BMI and short stature in childhood are associated with reduced risks of certain breast cancer subtypes. Thus, childhood body composition may play a role in the development of breast cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13058-022-01578-0. BioMed Central 2022-11-11 2022 /pmc/articles/PMC9652814/ /pubmed/36369105 http://dx.doi.org/10.1186/s13058-022-01578-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Pedersen, Dorthe C.
Jensen, Britt W.
Tjønneland, Anne
Andersen, Zorana J.
Mellemkjaer, Lene
Bjerregaard, Lise G.
Aarestrup, Julie
Baker, Jennifer L.
Birthweight, childhood body size, and timing of puberty and risks of breast cancer by menopausal status and tumor receptor subtypes
title Birthweight, childhood body size, and timing of puberty and risks of breast cancer by menopausal status and tumor receptor subtypes
title_full Birthweight, childhood body size, and timing of puberty and risks of breast cancer by menopausal status and tumor receptor subtypes
title_fullStr Birthweight, childhood body size, and timing of puberty and risks of breast cancer by menopausal status and tumor receptor subtypes
title_full_unstemmed Birthweight, childhood body size, and timing of puberty and risks of breast cancer by menopausal status and tumor receptor subtypes
title_short Birthweight, childhood body size, and timing of puberty and risks of breast cancer by menopausal status and tumor receptor subtypes
title_sort birthweight, childhood body size, and timing of puberty and risks of breast cancer by menopausal status and tumor receptor subtypes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652814/
https://www.ncbi.nlm.nih.gov/pubmed/36369105
http://dx.doi.org/10.1186/s13058-022-01578-0
work_keys_str_mv AT pedersendorthec birthweightchildhoodbodysizeandtimingofpubertyandrisksofbreastcancerbymenopausalstatusandtumorreceptorsubtypes
AT jensenbrittw birthweightchildhoodbodysizeandtimingofpubertyandrisksofbreastcancerbymenopausalstatusandtumorreceptorsubtypes
AT tjønnelandanne birthweightchildhoodbodysizeandtimingofpubertyandrisksofbreastcancerbymenopausalstatusandtumorreceptorsubtypes
AT andersenzoranaj birthweightchildhoodbodysizeandtimingofpubertyandrisksofbreastcancerbymenopausalstatusandtumorreceptorsubtypes
AT mellemkjaerlene birthweightchildhoodbodysizeandtimingofpubertyandrisksofbreastcancerbymenopausalstatusandtumorreceptorsubtypes
AT bjerregaardliseg birthweightchildhoodbodysizeandtimingofpubertyandrisksofbreastcancerbymenopausalstatusandtumorreceptorsubtypes
AT aarestrupjulie birthweightchildhoodbodysizeandtimingofpubertyandrisksofbreastcancerbymenopausalstatusandtumorreceptorsubtypes
AT bakerjenniferl birthweightchildhoodbodysizeandtimingofpubertyandrisksofbreastcancerbymenopausalstatusandtumorreceptorsubtypes